Telomir Pharmaceuticals, Common Stock Market Value
| TELO Stock | 4.19 0.19 4.34% |
| Symbol | Telomir |
Telomir Pharmaceuticals, Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Telomir Pharmaceuticals,. If investors know Telomir will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Telomir Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.63) | Return On Assets (0.84) | Return On Equity (6.87) |
The market value of Telomir Pharmaceuticals, is measured differently than its book value, which is the value of Telomir that is recorded on the company's balance sheet. Investors also form their own opinion of Telomir Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is Telomir Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Telomir Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect Telomir Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Telomir Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Telomir Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Telomir Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Telomir Pharmaceuticals, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Telomir Pharmaceuticals,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Telomir Pharmaceuticals,.
| 05/17/2024 |
| 11/13/2024 |
If you would invest 0.00 in Telomir Pharmaceuticals, on May 17, 2024 and sell it all today you would earn a total of 0.00 from holding Telomir Pharmaceuticals, Common or generate 0.0% return on investment in Telomir Pharmaceuticals, over 180 days. Telomir Pharmaceuticals, is related to or competes with Cullinan Oncology, Aerovate Therapeutics, Structure Therapeutics, Lyra Therapeutics, Gossamer Bio, and Inhibrx. Telomir Pharmaceuticals, is entity of United States More
Telomir Pharmaceuticals, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Telomir Pharmaceuticals,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Telomir Pharmaceuticals, Common upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.39 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 66.49 | |||
| Value At Risk | (9.48) | |||
| Potential Upside | 11.67 |
Telomir Pharmaceuticals, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Telomir Pharmaceuticals,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Telomir Pharmaceuticals,'s standard deviation. In reality, there are many statistical measures that can use Telomir Pharmaceuticals, historical prices to predict the future Telomir Pharmaceuticals,'s volatility.| Risk Adjusted Performance | 0.0184 | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (1.80) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0358 |
Telomir Pharmaceuticals, Backtested Returns
Telomir Pharmaceuticals, appears to be very risky, given 3 months investment horizon. Telomir Pharmaceuticals, owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0445, which indicates the firm had a 0.0445% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Telomir Pharmaceuticals, Common, which you can use to evaluate the volatility of the company. Please review Telomir Pharmaceuticals,'s Risk Adjusted Performance of 0.0184, coefficient of variation of 8371.42, and Semi Deviation of 6.13 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Telomir Pharmaceuticals, holds a performance score of 3. The entity has a beta of 2.8, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Telomir Pharmaceuticals, will likely underperform. Please check Telomir Pharmaceuticals,'s expected short fall, and the relationship between the maximum drawdown and rate of daily change , to make a quick decision on whether Telomir Pharmaceuticals,'s existing price patterns will revert.
Auto-correlation | 0.17 |
Very weak predictability
Telomir Pharmaceuticals, Common has very weak predictability. Overlapping area represents the amount of predictability between Telomir Pharmaceuticals, time series from 17th of May 2024 to 15th of August 2024 and 15th of August 2024 to 13th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Telomir Pharmaceuticals, price movement. The serial correlation of 0.17 indicates that over 17.0% of current Telomir Pharmaceuticals, price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.17 | |
| Spearman Rank Test | 0.29 | |
| Residual Average | 0.0 | |
| Price Variance | 0.74 |
Telomir Pharmaceuticals, lagged returns against current returns
Autocorrelation, which is Telomir Pharmaceuticals, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Telomir Pharmaceuticals,'s stock expected returns. We can calculate the autocorrelation of Telomir Pharmaceuticals, returns to help us make a trade decision. For example, suppose you find that Telomir Pharmaceuticals, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Telomir Pharmaceuticals, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Telomir Pharmaceuticals, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Telomir Pharmaceuticals, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Telomir Pharmaceuticals, stock over time.
Current vs Lagged Prices |
| Timeline |
Telomir Pharmaceuticals, Lagged Returns
When evaluating Telomir Pharmaceuticals,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Telomir Pharmaceuticals, stock have on its future price. Telomir Pharmaceuticals, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Telomir Pharmaceuticals, autocorrelation shows the relationship between Telomir Pharmaceuticals, stock current value and its past values and can show if there is a momentum factor associated with investing in Telomir Pharmaceuticals, Common.
Regressed Prices |
| Timeline |
Pair Trading with Telomir Pharmaceuticals,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Telomir Pharmaceuticals, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telomir Pharmaceuticals, will appreciate offsetting losses from the drop in the long position's value.Moving against Telomir Stock
| 0.6 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.36 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.32 | DNTH | Dianthus Therapeutics | PairCorr |
The ability to find closely correlated positions to Telomir Pharmaceuticals, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Telomir Pharmaceuticals, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Telomir Pharmaceuticals, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Telomir Pharmaceuticals, Common to buy it.
The correlation of Telomir Pharmaceuticals, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Telomir Pharmaceuticals, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Telomir Pharmaceuticals, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Telomir Pharmaceuticals, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Telomir Pharmaceuticals, Correlation, Telomir Pharmaceuticals, Volatility and Telomir Pharmaceuticals, Alpha and Beta module to complement your research on Telomir Pharmaceuticals,. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Telomir Pharmaceuticals, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.